Nanjing Medlander Medical Technology (688273) Income Statement & Earnings

47.98
-1.69-3.40%

Noon Break Jan 16 11:29 CST

4.80BMarket Cap47.27P/E (TTM)

Nanjing Medlander Medical Technology (688273) Income Statement

All

YOY

Hide blank lines

(Q9)Sep 30, 2025

(Q6)Jun 30, 2025

(Q1)Mar 31, 2025

(FY)Dec 31, 2024

(Q9)Sep 30, 2024

(Q6)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q9)Sep 30, 2023

(Q6)Jun 30, 2023

Total operating revenue

4.01%343.85M

5.62%241.22M

13.36%118.28M

24.57%424.55M

13.81%330.58M

11.73%228.38M

-4.39%104.34M

-9.57%340.82M

-2.64%290.46M

11.61%204.4M

Operating revenue

4.01%343.85M

5.62%241.22M

13.36%118.28M

24.57%424.55M

13.81%330.58M

11.73%228.38M

-4.39%104.34M

-9.57%340.82M

-2.64%290.46M

11.61%204.4M

Total operating cost

13.28%263.16M

12.93%173.67M

17.34%79.13M

17.16%322.31M

5.34%232.3M

-2.64%153.78M

-15.24%67.44M

1.14%275.11M

4.06%220.53M

14.09%157.96M

Operating cost

12.66%102.98M

13.83%70.19M

27.36%34.48M

20.89%119.04M

6.83%91.4M

-4.79%61.66M

-32.73%27.07M

-16.93%98.47M

-13.23%85.56M

-4.83%64.77M

Operating tax surcharges

-11.14%2.73M

-16.30%1.73M

12.81%585.73K

-4.24%4.74M

-14.87%3.07M

-22.89%2.06M

-52.77%519.22K

16.44%4.95M

23.00%3.61M

45.67%2.68M

Operating expense

7.51%71.26M

5.26%46.8M

-8.71%18.09M

13.51%93.68M

0.26%66.28M

0.44%44.46M

3.46%19.82M

-1.92%82.53M

6.41%66.11M

15.69%44.27M

Administration expense

15.83%44.32M

9.01%27.52M

11.09%12.09M

22.87%55.68M

15.35%38.26M

11.70%25.25M

10.81%10.89M

38.51%45.31M

44.82%33.17M

63.14%22.6M

Financial expense

91.33%-635.65K

86.17%-839.62K

84.41%-592.23K

43.35%-8.15M

31.99%-7.33M

-17.57%-6.07M

-32.26%-3.8M

-60.54%-14.38M

-310.31%-10.78M

-201.60%-5.16M

-Interest expense (Financial expense)

38.01%1.05M

38.58%614.87K

58.14%288.67K

178.69%1.06M

142.89%763.43K

107.29%443.7K

66.73%182.54K

26.59%380.94K

67.33%314.31K

65.81%214.04K

-Interest Income (Financial expense)

77.88%-1.8M

76.66%-1.52M

76.88%-922K

38.07%-9.21M

27.01%-8.13M

-21.24%-6.52M

-32.72%-3.99M

-59.75%-14.87M

-377.79%-11.14M

-190.50%-5.38M

Research and development

4.67%42.51M

6.99%28.27M

11.82%14.48M

-1.56%57.33M

-5.23%40.62M

-8.29%26.42M

6.78%12.95M

40.89%58.24M

53.18%42.86M

58.75%28.81M

Credit Impairment Loss

-167.40%-2.28M

-36.31%-1.36M

16.52%-361.46K

-109.81%-1.36M

-351.82%-853.14K

-658.02%-998.86K

-116.32%-433K

77.81%-647.63K

85.09%-188.82K

88.05%-131.77K

Asset Impairment Loss

---2.02M

----

-2,047.64%-9.82M

----

-31.11%-457.18K

----

Other net revenue

Fair value change income

26.17%1.42M

46.16%725.16K

289.36%643.93K

55.98%1.02M

219.71%1.13M

37.29%496.15K

---340.05K

--652.16K

--352.12K

157.93%361.39K

Invest income

144.22%5.3M

50.87%2.43M

-24.96%1.02M

-70.84%4.05M

-79.56%2.17M

-80.38%1.61M

-71.76%1.36M

74.28%13.89M

158.63%10.63M

532.57%8.19M

-Including: Investment income associates

-264.39%-1.8M

-498.29%-1.3M

-614.85%-746.63K

-152.48%-869.1K

-60.48%-495.23K

-0.75%-217.1K

26.95%-104.45K

-903.44%-344.22K

-366.39%-308.6K

-240.61%-215.49K

Asset deal income

80.18%-49.21K

----

-152.02%-122.18K

-6,751.93%-248.24K

----

--234.85K

--3.73K

----

Other revenue

62.75%20.99M

-52.88%4.56M

-41.41%2.67M

-20.11%18.46M

-23.77%12.9M

-18.71%9.68M

25.69%4.56M

-36.33%23.1M

-41.00%16.92M

0.24%11.91M

Operating profit

-8.22%104.06M

-15.81%71.89M

2.56%43.13M

11.69%114.46M

16.11%113.37M

27.87%85.39M

11.23%42.05M

-29.74%102.48M

-17.20%97.64M

17.35%66.78M

Add:Non operating Income

814.27%1.43M

294.17%241.44K

254.66%38.98K

12,264.01%11.34M

93.49%156.61K

2.22%61.25K

-17.92%10.99K

-15.66%91.76K

-13.94%80.94K

-20.47%59.92K

Less:Non operating expense

221.63%1.5M

317.59%931.7K

490.19%204.56

-38.03%678.59K

53.20%466.77K

48.80%223.12K

-99.41%34.66

1,458.28%1.1M

4,156.15%304.67K

1,284.89%149.94K

Total profit

-8.03%103.99M

-16.46%71.2M

2.62%43.16M

23.30%125.13M

16.06%113.06M

27.80%85.23M

11.23%42.06M

-30.44%101.48M

-17.45%97.42M

17.06%66.69M

Less:Income tax cost

-33.39%8.35M

-27.16%6.79M

0.20%3.88M

80.37%16.23M

15.54%12.53M

54.64%9.32M

-12.36%3.87M

-45.83%9M

-8.09%10.85M

7.31%6.03M

Net profit

-4.86%95.64M

-15.14%64.41M

2.87%39.28M

17.75%108.9M

16.13%100.53M

25.13%75.91M

14.36%38.19M

-28.47%92.48M

-18.49%86.57M

18.13%60.66M

Net profit from continuing operation

-4.86%95.64M

-15.14%64.41M

2.87%39.28M

17.75%108.9M

16.13%100.53M

25.13%75.91M

14.36%38.19M

-28.47%92.48M

-18.49%86.57M

18.13%60.66M

Less:Minority Profit

-108.06%-359.19K

-85.04%494.52K

-130.30%-576.04K

174.46%7.32M

143.46%4.46M

81.51%3.3M

88.74%1.9M

-64.93%2.67M

-77.41%1.83M

-61.13%1.82M

Net profit of parent company owners

-0.07%96M

-11.96%63.92M

9.85%39.86M

13.10%101.58M

13.37%96.07M

23.39%72.61M

12.04%36.29M

-26.19%89.82M

-13.62%84.74M

26.08%58.84M

Earning per share

Basic earning per share

0.87%0.9813

-10.90%0.6532

11.28%0.4073

14.77%1.0309

15.19%0.9728

24.97%0.7331

13.00%0.366

-38.49%0.8982

-33.04%0.8445

-5.74%0.5866

Diluted earning per share

0.87%0.9813

-10.90%0.6532

11.28%0.4073

14.77%1.0309

15.19%0.9728

24.97%0.7331

13.00%0.366

-38.49%0.8982

-33.04%0.8445

-5.74%0.5866

Other composite income

Total composite income

-4.86%95.64M

-15.14%64.41M

2.87%39.28M

17.75%108.9M

16.13%100.53M

25.13%75.91M

14.36%38.19M

-28.47%92.48M

-18.49%86.57M

18.13%60.66M

Total composite income of parent company owners

-0.07%96M

-11.96%63.92M

9.85%39.86M

13.10%101.58M

13.37%96.07M

23.39%72.61M

12.04%36.29M

-26.19%89.82M

-13.62%84.74M

26.08%58.84M

Total composite income of minority owners

-108.06%-359.19K

-85.04%494.52K

-130.30%-576.04K

174.46%7.32M

143.46%4.46M

81.51%3.3M

88.74%1.9M

-64.93%2.67M

-77.41%1.83M

-61.13%1.82M

Currency Unit

CNY

Accounting Standards

CAS (2007)

Audit Opinions

Unqualified opinion

Auditor

Tianheng Certified Public Accountants (Special General Partnership)

	(Q9)Sep 30, 2025	(Q6)Jun 30, 2025	(Q1)Mar 31, 2025	(FY)Dec 31, 2024	(Q9)Sep 30, 2024	(Q6)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q9)Sep 30, 2023	(Q6)Jun 30, 2023
Total operating revenue	4.01%343.85M	5.62%241.22M	13.36%118.28M	24.57%424.55M	13.81%330.58M	11.73%228.38M	-4.39%104.34M	-9.57%340.82M	-2.64%290.46M	11.61%204.4M
Operating revenue	4.01%343.85M	5.62%241.22M	13.36%118.28M	24.57%424.55M	13.81%330.58M	11.73%228.38M	-4.39%104.34M	-9.57%340.82M	-2.64%290.46M	11.61%204.4M
Total operating cost	13.28%263.16M	12.93%173.67M	17.34%79.13M	17.16%322.31M	5.34%232.3M	-2.64%153.78M	-15.24%67.44M	1.14%275.11M	4.06%220.53M	14.09%157.96M
Operating cost	12.66%102.98M	13.83%70.19M	27.36%34.48M	20.89%119.04M	6.83%91.4M	-4.79%61.66M	-32.73%27.07M	-16.93%98.47M	-13.23%85.56M	-4.83%64.77M
Operating tax surcharges	-11.14%2.73M	-16.30%1.73M	12.81%585.73K	-4.24%4.74M	-14.87%3.07M	-22.89%2.06M	-52.77%519.22K	16.44%4.95M	23.00%3.61M	45.67%2.68M
Operating expense	7.51%71.26M	5.26%46.8M	-8.71%18.09M	13.51%93.68M	0.26%66.28M	0.44%44.46M	3.46%19.82M	-1.92%82.53M	6.41%66.11M	15.69%44.27M
Administration expense	15.83%44.32M	9.01%27.52M	11.09%12.09M	22.87%55.68M	15.35%38.26M	11.70%25.25M	10.81%10.89M	38.51%45.31M	44.82%33.17M	63.14%22.6M
Financial expense	91.33%-635.65K	86.17%-839.62K	84.41%-592.23K	43.35%-8.15M	31.99%-7.33M	-17.57%-6.07M	-32.26%-3.8M	-60.54%-14.38M	-310.31%-10.78M	-201.60%-5.16M
-Interest expense (Financial expense)	38.01%1.05M	38.58%614.87K	58.14%288.67K	178.69%1.06M	142.89%763.43K	107.29%443.7K	66.73%182.54K	26.59%380.94K	67.33%314.31K	65.81%214.04K
-Interest Income (Financial expense)	77.88%-1.8M	76.66%-1.52M	76.88%-922K	38.07%-9.21M	27.01%-8.13M	-21.24%-6.52M	-32.72%-3.99M	-59.75%-14.87M	-377.79%-11.14M	-190.50%-5.38M
Research and development	4.67%42.51M	6.99%28.27M	11.82%14.48M	-1.56%57.33M	-5.23%40.62M	-8.29%26.42M	6.78%12.95M	40.89%58.24M	53.18%42.86M	58.75%28.81M
Credit Impairment Loss	-167.40%-2.28M	-36.31%-1.36M	16.52%-361.46K	-109.81%-1.36M	-351.82%-853.14K	-658.02%-998.86K	-116.32%-433K	77.81%-647.63K	85.09%-188.82K	88.05%-131.77K
Asset Impairment Loss	---2.02M	---2.02M	----	-2,047.64%-9.82M	----	----	----	-31.11%-457.18K	----	----
Other net revenue
Fair value change income	26.17%1.42M	46.16%725.16K	289.36%643.93K	55.98%1.02M	219.71%1.13M	37.29%496.15K	---340.05K	--652.16K	--352.12K	157.93%361.39K
Invest income	144.22%5.3M	50.87%2.43M	-24.96%1.02M	-70.84%4.05M	-79.56%2.17M	-80.38%1.61M	-71.76%1.36M	74.28%13.89M	158.63%10.63M	532.57%8.19M
-Including: Investment income associates	-264.39%-1.8M	-498.29%-1.3M	-614.85%-746.63K	-152.48%-869.1K	-60.48%-495.23K	-0.75%-217.1K	26.95%-104.45K	-903.44%-344.22K	-366.39%-308.6K	-240.61%-215.49K
Asset deal income	80.18%-49.21K	----	----	-152.02%-122.18K	-6,751.93%-248.24K	----	----	--234.85K	--3.73K	----
Other revenue	62.75%20.99M	-52.88%4.56M	-41.41%2.67M	-20.11%18.46M	-23.77%12.9M	-18.71%9.68M	25.69%4.56M	-36.33%23.1M	-41.00%16.92M	0.24%11.91M
Operating profit	-8.22%104.06M	-15.81%71.89M	2.56%43.13M	11.69%114.46M	16.11%113.37M	27.87%85.39M	11.23%42.05M	-29.74%102.48M	-17.20%97.64M	17.35%66.78M
Add:Non operating Income	814.27%1.43M	294.17%241.44K	254.66%38.98K	12,264.01%11.34M	93.49%156.61K	2.22%61.25K	-17.92%10.99K	-15.66%91.76K	-13.94%80.94K	-20.47%59.92K
Less:Non operating expense	221.63%1.5M	317.59%931.7K	490.19%204.56	-38.03%678.59K	53.20%466.77K	48.80%223.12K	-99.41%34.66	1,458.28%1.1M	4,156.15%304.67K	1,284.89%149.94K
Total profit	-8.03%103.99M	-16.46%71.2M	2.62%43.16M	23.30%125.13M	16.06%113.06M	27.80%85.23M	11.23%42.06M	-30.44%101.48M	-17.45%97.42M	17.06%66.69M
Less:Income tax cost	-33.39%8.35M	-27.16%6.79M	0.20%3.88M	80.37%16.23M	15.54%12.53M	54.64%9.32M	-12.36%3.87M	-45.83%9M	-8.09%10.85M	7.31%6.03M
Net profit	-4.86%95.64M	-15.14%64.41M	2.87%39.28M	17.75%108.9M	16.13%100.53M	25.13%75.91M	14.36%38.19M	-28.47%92.48M	-18.49%86.57M	18.13%60.66M
Net profit from continuing operation	-4.86%95.64M	-15.14%64.41M	2.87%39.28M	17.75%108.9M	16.13%100.53M	25.13%75.91M	14.36%38.19M	-28.47%92.48M	-18.49%86.57M	18.13%60.66M
Less:Minority Profit	-108.06%-359.19K	-85.04%494.52K	-130.30%-576.04K	174.46%7.32M	143.46%4.46M	81.51%3.3M	88.74%1.9M	-64.93%2.67M	-77.41%1.83M	-61.13%1.82M
Net profit of parent company owners	-0.07%96M	-11.96%63.92M	9.85%39.86M	13.10%101.58M	13.37%96.07M	23.39%72.61M	12.04%36.29M	-26.19%89.82M	-13.62%84.74M	26.08%58.84M
Earning per share
Basic earning per share	0.87%0.9813	-10.90%0.6532	11.28%0.4073	14.77%1.0309	15.19%0.9728	24.97%0.7331	13.00%0.366	-38.49%0.8982	-33.04%0.8445	-5.74%0.5866
Diluted earning per share	0.87%0.9813	-10.90%0.6532	11.28%0.4073	14.77%1.0309	15.19%0.9728	24.97%0.7331	13.00%0.366	-38.49%0.8982	-33.04%0.8445	-5.74%0.5866
Other composite income
Total composite income	-4.86%95.64M	-15.14%64.41M	2.87%39.28M	17.75%108.9M	16.13%100.53M	25.13%75.91M	14.36%38.19M	-28.47%92.48M	-18.49%86.57M	18.13%60.66M
Total composite income of parent company owners	-0.07%96M	-11.96%63.92M	9.85%39.86M	13.10%101.58M	13.37%96.07M	23.39%72.61M	12.04%36.29M	-26.19%89.82M	-13.62%84.74M	26.08%58.84M
Total composite income of minority owners	-108.06%-359.19K	-85.04%494.52K	-130.30%-576.04K	174.46%7.32M	143.46%4.46M	81.51%3.3M	88.74%1.9M	-64.93%2.67M	-77.41%1.83M	-61.13%1.82M
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)
Audit Opinions	--	--	--	--	--	--	--	Unqualified opinion	--	--
Auditor	--	--	--	--	--	--	--	Tianheng Certified Public Accountants (Special General Partnership)	--	--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More

牛牛課堂

Oct 13, 2025 18:05

[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?

Food流油

Apr 14, 2025 15:43

"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"